Literature DB >> 15228990

Evidence for a prospective anti-osteoporosis effect of black tea (Camellia Sinensis) extract in a bilaterally ovariectomized rat model.

Asankur Sekhuar Das1, Maitrayee Mukherjee, Chandan Mitra.   

Abstract

The purpose of this study was to examine whether whole aqueous black tea extract (BTE) prevents bone loss induced by ovarian hormone deficiency. Eighteen 95-100 days old female albino rats were randomly assigned to three treatment groups [sham -operated control (sham); bilaterally ovariectomized (ovx) and ovx + aqueous black tea extract (BTE) ] and sacrificed after 28 days. All animals were fed a standard laboratory diet with free access to deionized water except on days of urinary parameter studies when animals were given only calcium free deionized water during the entire 24 h period of urine collection. Body weight study revealed that rats in the ovx group had significantly higher final body weight than rats in the sham group. This higher final body weight was not observed in animals receiving BTE. The ovx group also had significantly higher abdominal fat mass and liver weight and significantly lower uterus, right kidney and left kidney weights than in other two groups. All these organ weight changes in ovx group also were not observed in animals receiving BTE. Results of urinary studies revealed that rats in the ovx group had significantly higher urinary excretion of calcium (Ca), phosphate, creatinine (Cr), calcium to creatinine (Ca:Cr) ratio (P< 0.001) and hydroxyproline (HPr) (P< 0.01) than rats in the sham group. Significant recovery of all these parameters were observed in animals receiving BTE. The ovx group also had significantly higher (P< 0.001) serum alkaline phosphatase (AP) and tartrate-resistant acid phosphatase (TRAP) activity than rats in the other two groups. These changes could not be seen in animals receiving BTE. Also, identical changes were seen in bone density experiments. Rats in the ovx group had significantly lower densities of the right femur (P<0.001), eighth thoracic rib (P< 0.001), eighth thoracic vertebra (P< 0.05), and fourth lumbar vertebra (P< 0.01) than rats in the sham group; and significant improvement in densities of these bones were seen in animals supplemented with BTE. Animals of ovx group also showed significant decrease in calcium and phosphate level in all these bones which could be regained significantly when these animals were supplemented with BTE. Our findings suggest that aqueous BTE may be effective in preventing bone loss due to ovarian hormone deficiency. Because serum activity of AP, TRAP and urinary loss of bone minerals (Ca and Phosphate) and also the organic components of bone (Cr and HPr) were significantly greater in the ovx group, compared to sham animals and ovx + BTE group. This confirms that ovariectomy enhances and BTE suppresses the rate of bone turnover. The density results of ovx + BTE group are significantly greater than rats in the ovx group, suggesting further that formation exceeded resorption. Detailed studies are underway to clarify the mechanism of this protective effect of BTE on hypogonadal bone loss.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15228990

Source DB:  PubMed          Journal:  Asia Pac J Clin Nutr        ISSN: 0964-7058            Impact factor:   1.662


  10 in total

Review 1.  Tea and bone health: steps forward in translational nutrition.

Authors:  Chwan-Li Shen; Ming-Chien Chyu; Jia-Sheng Wang
Journal:  Am J Clin Nutr       Date:  2013-10-30       Impact factor: 7.045

2.  Are there differences between Sprague-Dawley and Wistar rats in long-term effects of ovariectomy as a model for postmenopausal osteoporosis?

Authors:  Ji Fang; Li Yang; Ronghua Zhang; Xiaofeng Zhu; Panpan Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

3.  The Use of Mushrooms and Spirulina Algae as Supplements to Prevent Growth Inhibition in a Pre-Clinical Model for an Unbalanced Diet.

Authors:  Roni Sides; Shelley Griess-Fishheimer; Janna Zaretsky; Astar Shitrit; Rotem Kalev-Altman; Reut Rozner; Olga Beresh; Maïtena Dumont; Svetlana Penn; Ron Shahar; Efrat Monsonego-Ornan
Journal:  Nutrients       Date:  2021-11-29       Impact factor: 5.717

4.  Protective Role of Black Tea Extract against Nonalcoholic Steatohepatitis-Induced Skeletal Dysfunction.

Authors:  Subhra Karmakar; Sangita Majumdar; Anasuya Maiti; Monalisa Choudhury; Aniruddha Ghosh; Asankur S Das; Chandan Mitra
Journal:  J Osteoporos       Date:  2011-06-23

5.  Pu-erh Tea Extract Ameliorates Ovariectomy-Induced Osteoporosis in Rats and Suppresses Osteoclastogenesis In Vitro.

Authors:  Titi Liu; Shihua Ding; Dan Yin; Xiangdan Cuan; Chuanqi Xie; Huanhuan Xu; Xuanjun Wang; Jun Sheng
Journal:  Front Pharmacol       Date:  2017-05-31       Impact factor: 5.810

6.  Effect of Black Tea Extract and Thearubigins on Osteoporosis in Rats and Osteoclast Formation in vitro.

Authors:  Qingqing Liang; Ming Lv; Xiaojuan Zhang; Jun Hu; Ying Wu; Yewei Huang; Xuanjun Wang; Jun Sheng
Journal:  Front Physiol       Date:  2018-09-03       Impact factor: 4.566

Review 7.  Flavonoids as natural phenolic compounds and their role in therapeutics: an overview.

Authors:  Rakesh E Mutha; Anilkumar U Tatiya; Sanjay J Surana
Journal:  Futur J Pharm Sci       Date:  2021-01-20

8.  Wnt-signaling-mediated antiosteoporotic activity of porcine placenta hydrolysates in ovariectomized rats.

Authors:  Byoung-Seob Ko; Da Sol Kim; Suna Kang; Na Ra Lee; Jin Ah Ryuk; Sunmin Park
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-03       Impact factor: 2.629

9.  Black tea may be a prospective adjunct for calcium supplementation to prevent early menopausal bone loss in a rat model of osteoporosis.

Authors:  Asankur Sekhar Das; Maitrayee Banerjee; Dolan Das; Sandip Mukherjee; Chandan Mitra
Journal:  J Osteoporos       Date:  2013-07-24

10.  Black Tea Exhibits a Dose-Dependent Response in Saos-2 Cell Mineralization.

Authors:  Riley E Cleverdon; Michael D McAlpine; Wendy E Ward
Journal:  J Med Food       Date:  2020-03-24       Impact factor: 2.786

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.